John W. Hubbard
- Psychiatry and Mental health top 1%
- Epilepsy research and treatment 17
- Schizophrenia research and treatment 14
- Behavioral Neuroscience top 2%
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 27
- Antibiotics Pharmacokinetics and Efficacy 14
- Biological Psychiatry top 5%
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 27
- Antibiotics Pharmacokinetics and Efficacy 14
-
- Analytical Chemistry and Chromatography 20
-
- Drug Transport and Resistance Mechanisms 20
-
- Analytical Methods in Pharmaceuticals 19
-
- Statistical Methods in Clinical Trials 14
- Co-authors
- K.K. MidhaKamal K. MidhaE. D. KorchinskiMaureen J. RawsonG. McKayJames E. LawlerNuggehally R. SrinivasJ.K. Cooper
- Journals
- Brain Research (2 papers)Journal of Applied Physiology (1 paper)Journal of Controlled Release (1 paper)
- Partner nations
- CanadaUnited StatesSwitzerland
In The Last Decade
John W. Hubbard
148 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 126
- Psychiatry and Mental health 935
- Behavioral Neuroscience 218
- Pharmacology 418
- Biological Psychiatry 72
- Pharmacology 458
Countries citing papers authored by John W. Hubbard
This map shows the geographic impact of John W. Hubbard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Hubbard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Hubbard more than expected).
Fields of papers citing papers by John W. Hubbard
This network shows the impact of papers produced by John W. Hubbard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Hubbard. The network helps show where John W. Hubbard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John W. Hubbard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Towards a global data network for the geosciences | 2009 | 1 |
| 2 | 2005 | 60 | |
| 3 | 2001 | 35 | |
| 4 | 1997 | 16 | |
| 5 | 1997 | 8 | |
| 6 | 1995 | 1 | |
| 7 | 1995 | 5 | |
| 8 | 1993 | 64 | |
| 9 | 1991 | 0 | |
| 10 | 1991 | 32 | |
| 11 | 1990 | 21 | |
| 12 | 1990 | 8 | |
| 13 | 1989 | 32 | |
| 14 | 1989 | 47 | |
| 15 | 1989 | 19 | |
| 16 | 1988 | 13 | |
| 17 | 1988 | 3 | |
| 18 | 1988 | 4 | |
| 19 | 1981 | 5 | |
| 20 | alpha-Methyldopamine, a key intermediate in the metabolic disposition of 3,4-methylenedioxyamphetamine in vivo in dog and monkey. | 1978 | 20 |
About John W. Hubbard
John W. Hubbard is a scholar working on Pharmacology, Behavioral Neuroscience and Psychiatry and Mental health, having authored 152 papers that have together received 2.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (27 papers), Analytical Chemistry and Chromatography (20 papers), Drug Transport and Resistance Mechanisms (20 papers), Analytical Methods in Pharmaceuticals (19 papers), Epilepsy research and treatment (17 papers), Statistical Methods in Clinical Trials (14 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Schizophrenia research and treatment (14 papers). The work is most often cited by research in Psychiatry and Mental health (935 citations), Behavioral Neuroscience (218 citations) and Pharmacology (418 citations). John W. Hubbard has collaborated with scholars based in Canada, United States and Switzerland. Frequent co-authors include K.K. Midha, Kamal K. Midha, E. D. Korchinski, Maureen J. Rawson, G. McKay, James E. Lawler, Nuggehally R. Srinivas, J.K. Cooper, E. M. Hawes and Declan Quinn. Their work appears in journals such as Brain Research, Journal of Applied Physiology and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.